Theremia
Entrepreneur First '24Paris, FR · Founded 2024 · 3 known investors
Theremia develops statistical methods for analyzing clinical trial outcomes, including a Nearest Neighbor Pairing approach to improve Win Ratio estimation of individual causal treatment effects in heterogeneous patient populations. Its work targets precision medicine and drug benefit-risk assessment, with attention to adverse drug reactions and CNS treatments.
Founders & leadership
Theremia was founded in 2024 by Iris Maréchal and Chloé Geoffroy.
IM
Iris MaréchalinCEOIris Maréchal began her career in management consulting at BCG, where her client work included major global pharmaceutical firms. While still a student, she launched a nonprofit organization that she scaled to operate nationally.
CG
Chloé GeoffroyinCofounderChloé Geoffroy is trained as both a pharmacist and a chemical engineer. She earned her PhD and completed postdoctoral research in neuropharmacology at the École Normale Supérieure.
ME
Mathieu EvensResearcher
Investors · 3
Frequently asked questions
- What does Theremia do?
- Theremia develops statistical methods for analyzing clinical trial outcomes, including a Nearest Neighbor Pairing approach to improve Win Ratio estimation of individual causal treatment effects in heterogeneous patient populations. Its work targets precision medicine and drug benefit-risk assessment, with attention to adverse drug reactions and CNS treatments.
- Who founded Theremia?
- Theremia was founded by Iris Maréchal, Chloé Geoffroy in 2024.
- Who are Theremia's investors?
- Theremia's investors include Agoranov, Entrepreneur First, Salica Investments.
- Where is Theremia headquartered?
- Theremia is headquartered in Paris, FR.